Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorder.
Key Points
PEth serves as an objective measure of heavy drinking days, enhancing accuracy in clinical assessments.
Findings indicate significant promise for PEth in monitoring alcohol consumption patterns in individuals.
Assessment involved the use of phosphatidylethanol levels to gauge drinking days versus self-reports, showing distinct advantages.
Validating these findings in larger cohorts calls for further investigation to ensure reliability across diverse populations.
Abstract
Our findings support the use of PEth as an objective measure of heavy drinking days in a clinical setting. Further research is needed to validate these findings in larger cohorts.